TY  - CONF
AU  - Studer, A. Garcia
AU  - Rojas-Gimenez, M.
AU  - Feijoo, M. Velloso
AU  - Romero-Barco, C. M.
AU  - Godoy-Navarrete, F.
AU  - Mena-Vazquez, N.
PY  - 2022
DO  - 10.1136/annrheumdis-2022-eular.1825
SN  - 0003-4967
UR  - http://hdl.handle.net/10668/20074
T2  - Annals of the rheumatic diseases
AB  - Background: Intersticial lung disease (ILD) is a common condition in patientswith systemic autoinmune diseases (SAI) that is characterized by increasedmorbility and mortality. Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has posed huge...
LA  - en
PB  - BMJ Group
KW  - Área de Gestión Sanitaria Sur de Sevilla
TI  - SARS-COV-2 INFECTION AND IT VACCINATION IN AUTOINMUNE DISEASE-ASSOCIATED INTERSTICIAL LUNG DISEASE
TY  - conference output
VL  - 81
ER  -